This pool includes 53 peptides derived from a peptide scan (15mers with 11 aa overlap) through the entire Membrane protein (Protein ID: P0DTC5) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays.

Somatostatin analogue

SMS 201-995 belongs to somatostatin analog that is three times more potent than the native hormone in inhibiting the secretion of growth hormone. SMS 201-995 can lower plasma concentrations of growth hormone and somatomedin-C in patients with pituitary acromegaly. Somatostatin analogues have been suggested as possible therapy for human pancreatic cancer.

DYKDDDDK tag;Flag-tag

A fusion tag, called DYKDDDDK and consisting of eight amino acids (Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys) including an enterokinase-cleavage site, was specifically designed for immunoaffinity chromatography. It allows elution under non-denaturing conditions. Several antibodies against this peptide have been developed. One antibody, denoted as M1, binds the peptide in the presence of bivalent metal cations, preferably Ca2+. Elution is effected by chelating agents. Another strategy is competitive elution with excess of free DYKDDDDK peptide.

CNP (1-22), humanCNP

C-type natriuretic peptide is produced in the hypothalamus, anterior pituitary, and most major endocrine glands. C-type natriuretic peptide has potent venodilatory and coronary vasodilatory effects, but minimal effects on renal function.

GnRH-I is a small 10 amino acid long peptide (decapeptide) from the hypothalamus. GnRH-I acts at the hypophysis to cause an increase in release of biologically active Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH) in the blood, which in turn stimulate the development of the tests in the growing made animal and the synthesis of male steroids. In the growing female animal the development of the ovaries is stimulated, as is the development of follicles within the ovary, synthesis of female steroids, and ovulation.

This peptide is an ideal novel targeted non-viral gene delivery vector, which was easy to be synthesized, high efficient and low cytotoxicity.

SARS-CoV-2 Spike Glycoprotein-Omicron-90% purity

This pool is delivered in one pool of 53 peptides derived from a peptide scan through Spike glycoprotein - Receptor binding domain of SARS-CoV-2 (Lineage P.1, Brazil, Gamma, previously B.1.1.248 / B.1.1.28.1) covering the following mutations: K0417T, E0484K, N0501Y for T cell assays (e.g. ELISPOT).

This pool is delivered in one pool of 53 peptides derived from a peptide scan (15mers with 11 aa overlap) through Spike glycoprotein - Receptor binding domain (mutation: N501Y) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).

This pool is delivered in two subpools of 146 & 145 peptides derived from a peptide scan (15mers with 11 aa overlap) through the entire Spike glycoprotein (Protein ID: P15423) of Human coronavirus 229E (HCoV-229E) for T cell assays.